Sartorius Stedim Biotech (SSB) and G-Con Manufacturing have formed a global collaboration to offer highly advanced and flexible production platforms for the biopharmaceutical manufacturing industry. The new product line will leverage G-Con’s modular, mobile clean-room “pods” and SSB’s broad single-use and reusable product portfolio to create a totally integrated production process platform.

SSB has incorporated its products into unit operations for media/buffer preparation, seed fermentation, cell cultivation and harvesting, ultra-diafiltration, membrane chromatography and viral clearance for biopharmaceutical development and manufacturing. Combining SSB’s technology with G-Con’s modular, scalable and flexible pod platform will provide the biopharmaceutical manufacturing industry with a set of cost-effective, “plug and play” tools for next-generation manufacturing facilities.

“Our vision is to create standardized unit operations, implemented into the self-contained G-Con modules,” said Maik Jomitz, SSB’s senior vice president of marketing for Bioprocess Solutions. “These modules can be used as individual process units or joined to an entire process.”

Effective immediately, G-Con’s modular containment units are available through SSB’s Integrated Solutions unit and will be rolled out globally in early 2012.